BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the start of shipments for its latest benchtop sequencer, Platinum® Pro. This groundbreaking instrument offers protein analysis with single-molecule precision, aiming to make Next-Gen Protein Sequencing™ more accessible to laboratories worldwide. Platinum Pro delivers a comprehensive solution for sequencing and analyzing […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the company’s long-term regional growth strategy. The new Customer Experience Centre is scheduled to open in summer 2026 and will feature a state-of-the-art […]
Overview: WALTHAM, MASS. — Designed to meet the needs of clinical laboratories by offering compliance to regulatory mandates, efficiency, ease of use, and run schedule flexibility, Thermo Fisher Scientific is introducing the Applied Biosystems™ SeqStudio™ Flex Dx Genetic Analyzer. SeqStudio Flex Dx is an IVDR-compliant capillary electrophoresis (CE) system that supports both clinical as well […]
SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has partnered with BioTuring, developer of advanced bioinformatics algorithms and software that enables rapid OMICS analysis, to offer researchers access to SpatialX, a powerful deep-learning tool for unified multi-technology spatial data analysis compatible with STOmics chemistries designed to […]
BOSTON — Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, today announced a comprehensive collaboration with Cell Signaling Technology (CST), a global leader in high-quality research antibodies and associated reagents. This collaboration will explore Leveragen’s proprietary Singularity Musculus platform to expedite the development of mouse-derived nanobodies tailored for reagent antibody […]
Christian Uhrich, Investment Director at M Ventures, joins Vizgen Board of Directors; Chad Brown joins the company as Chief Commercial Officer CAMBRIDGE, Mass. — Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced two key appointments aimed at advancing the company’s future strategy and execution. Christian Uhrich, […]
Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH — Audax Strategic Capital (“ASC” or “Audax”), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners (“Riverarch”) and an established manufacturer and distributor of specialty […]
SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atlas (HCA) to offer its STOmics spatial transcriptomics products to HCA members. Human Cell Atlas (HCA), an international collaborative research consortium, is mapping all cell types in the […]
Stephen MacMillan to retire from the Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive Chair of Illumina’s Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, […]
The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). Dan brings a wealth of experience from the life science and healthcare industries, having held leadership roles at e.g. QleanAir, Carmel Pharma and Mölnlycke. Most recently, he served as CEO of Coala […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
